Revatis S.A.
PrivateLast Round
Grant
Jan 18, 2024
Total Funding Raised
$2.55M
Company Overview
Revatis S.A. operates in Healthcare & Life Sciences and is based in Marche-en-Famenne. Its latest recorded funding round was a Grant round in January 2024.
Revatis S.A. is a biotechnology company that provides regenerative medicine and cell therapy products and services for veterinary and human applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revatis S.A. Comparables
Compare Revatis S.A. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EquiCord | 81% | |
| Animacel | 80% | |
| eQcell Inc. | 79% |
For institutional investors. Book with your work email.
Revatis S.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 18, 2024 | ||||
| VC Round | Jul 10, 2023 | ||||
| Angel | Jan 27, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Revatis S.A. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Luxembourg Développement | Angel |
| Noshaq | Angel, VC Round |
| Walloon Region (Belgium) | Grant |
| BeAngels | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Grew 27% QoQ, from 11 to 14 employees.
- May 1, 2025
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Revatis S.A. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Revatis S.A.'s valuation, stock price, and market status.
Is Revatis S.A. a public or private company?
Revatis S.A. is a private company.
What is the current stock price of Revatis S.A.?
Revatis S.A. is a private company, so its shares have no public market price. Caplight tracks Revatis S.A.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Revatis S.A. worth (valuation)?
Valuation information for Revatis S.A. is not publicly available.
Can I buy Revatis S.A. stock?
Revatis S.A. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Revatis S.A.'s last funding round?
Revatis S.A.'s most recent funding round was Grant on January 18, 2024.
Who are the main investors in Revatis S.A.?
Key investors in Revatis S.A. include Luxembourg Développement, Noshaq, Walloon Region (Belgium), BeAngels.
Will Revatis S.A. IPO soon?
No public IPO plans have been announced for Revatis S.A..
How can I track Revatis S.A. secondary market activity?
Caplight tracks bids, offers, and trades in Revatis S.A.'s shares on secondary markets.